RT Journal Article
SR Electronic
T1 High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003246
DO 10.1136/jitc-2021-003246
VO 9
IS 8
A1 Ager, Casey R
A1 Boda, Akash
A1 Rajapakshe, Kimal
A1 Lea, Spencer Thomas
A1 Di Francesco, Maria Emilia
A1 Jayaprakash, Priyamvada
A1 Slay, Ravaen B
A1 Morrow, Brittany
A1 Prasad, Rishika
A1 Dean, Meghan A
A1 Duffy, Colm R
A1 Coarfa, Cristian
A1 Jones, Philip
A1 Curran, Michael A
YR 2021
UL http://jitc.bmj.com/content/9/8/e003246.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.